Publishing research using ab92536? Please let us know so that we can cite the reference in this datasheet.

ab92536 has been referenced in 8 publications.

  • Duan Y  et al. Targeted silencing of CXCR4 inhibits epithelial-mesenchymal transition in oral squamous cell carcinoma. Oncol Lett 12:2055-2061 (2016). WB . PubMed: 27602138
  • She S  et al. C-reactive protein is a biomarker of AFP-negative HBV-related hepatocellular carcinoma. Int J Oncol 47:543-54 (2015). PubMed: 26058824
  • Li C  et al. Inhibitory effects of kaempferol on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9. Biochem Cell Biol 93:16-27 (2015). Human . PubMed: 25453494
  • Li C  et al. Inhibitory Effects of Isorhamnetin on the Invasion of Human Breast Carcinoma Cells by Downregulating the Expression and Activity of Matrix Metalloproteinase-2/9. Nutr Cancer 67:1191-200 (2015). Human . PubMed: 26359917
  • Feng J  et al. Overexpression of peroxiredoxin 2 inhibits TGF-ß1-induced epithelial-mesenchymal transition and cell migration in colorectal cancer. Mol Med Rep 10:867-73 (2014). WB ; Human . PubMed: 24920174
  • Liu Y  et al. The role of von Willebrand factor as a biomarker of tumor development in hepatitis B virus-associated human hepatocellular carcinoma: a quantitative proteomic based study. J Proteomics 106:99-112 (2014). WB ; Human . PubMed: 24769235
  • Ko SY  et al. Cell migration is regulated by AGE-RAGE interaction in human oral cancer cells in vitro. PLoS One 9:e110542 (2014). PubMed: 25330185
  • Nucera C  et al. B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression. Proc Natl Acad Sci U S A 107:10649-54 (2010). PubMed: 20498063

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"